Takao Taguchi
About
In The Last Decade
Takao Taguchi
62 papers receiving 429 citations
Peers
Comparison fields: 5 of 88
- Electrical and Electronic Engineering 209
- Biomedical Engineering 94
- Radiation 72
- Surfaces, Coatings and Films 66
- Plant Science 51
Countries citing papers authored by Takao Taguchi
This map shows the geographic impact of Takao Taguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takao Taguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takao Taguchi more than expected).
Fields of papers citing papers by Takao Taguchi
This network shows the impact of papers produced by Takao Taguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takao Taguchi. The network helps show where Takao Taguchi may publish in the future.
Co-authorship network of co-authors of Takao Taguchi
This figure shows the co-authorship network connecting the top 25 collaborators of Takao Taguchi. A scholar is included among the top collaborators of Takao Taguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takao Taguchi. Takao Taguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 15 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 8 | |
| 9 | 1 | |
| 10 | 25 | |
| 11 | 10 | |
| 12 | 7 | |
| 13 | [Combination therapy of high dose doxifluridine (5'-DFUR)+mitomycin C (MMC) for advanced or recurrent colorectal cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs]. | 2 |
| 14 | Phase I study of YM 881 (zinostatin stimalamer) suspension by hepatic arterial infusion | 2 |
| 15 | 8 | |
| 16 | 8 | |
| 17 | 16 | |
| 18 | Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey. | 34 |
| 19 | [Results of phase III study of lentinan]. | 28 |
| 20 | [Clinical evaluation of SPG (schizophyllan) as a therapeutic adjuvant after surgery of gastric cancer--controlled study by an envelope method]. | 22 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.